Trading Ideas Bristol-Myers Squibb Company Lima

Equities

End-of-day quote Lima Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
40.86 ^USD	+0.29%		+0.29%	-20.43%

Jul. 16	Goldman Sachs Trims Price Target on Bristol-Myers Squibb to $55 From $56, Buy Rating Maintained	MT
Jul. 15	Transcript : Bristol-Myers Squibb Company Presents at UBS Virtual Targeted Protein Degradation Day, Jul-15-2024 11:00 AM

BRISTOL-MYERS SQUIBB COMPANY :The beginning of the move	19-09-18
BRISTOL-MYERS SQUIBB COMPANY :Underpinned by a support level	19-04-08
BRISTOL-MYERS SQUIBB COMPANY :Attractive price levels	16-09-26

No results for this search

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST